Categories: Technology

Notice to convene the Annual General Meeting 2026

Company announcement
No. 11/2025

                                             6 February 2026

Notice to convene the Annual General Meeting 2026

The Annual General Meeting of Netcompany Group A/S will be held on Thursday, 5 March 2026 at 15:00 (CET).

The Annual General Meeting will be held completely electronically and admission and participation in the General Meeting will solely take place via the internet in accordance with the Articles of Association section 7.2 and as further described in the notice. Physical attendance will not be possible.

The notice to convene the Annual General Meeting, including appendix 1 (Description of the candidates for the Board of Directors) is enclosed.

Further information about the Annual General Meeting is available at:
https://netcompany.com/investor/general-meetings/.

Additional information
For additional information, please contact:

Additional information
For additional information, please contact:

Netcompany Group A/S
Thomas Johansen, CFO, +45 51 19 32 24
Frederikke Linde, Head of IR, +45 60 62 60 87

GlobeNews Wire

Recent Posts

Pinecone Launches First Serverless Region in Asia with New Singapore Cloud Region, Bringing the Knowledge Infrastructure for AI to the Asia-Pacific Market

Alongside new availability on AWS ap-southeast-1, Pinecone announces Nexus knowledge engine, KnowQL query language, Marketplace,…

51 minutes ago

Kroll Appoints Renowned Professional Services Executive Fred Crawford as Executive Chairman

Fred Crawford brings decades of experience building and scaling advisory firms to help support and…

51 minutes ago

Maropost Launches a New Partner Portal to Supercharge Global Growth

TORONTO, May 4, 2026 /PRNewswire/ -- Maropost, the leading unified commerce platform, today announced the…

51 minutes ago

Lee Cowie appointed CEO of accesso as company accelerates AI strategy

COO steps up as founder Steve Brown passes the baton in planned handover; transition follows…

51 minutes ago

Cellenkos Announces FDA Clearance of Investigational New Drug (IND) Application for Phase 1b/ 2a Trial of CK0802 in Steroid-Refractory Graft-versus-Host Disease (GVHD)

Multicenter, open-label study will evaluate the safety and preliminary efficacy of CK0802, a first-in-class, off-the-shelf…

2 hours ago

Making Waves Across Borders: Manipal Hospitals Presents the First-Ever Sri Lanka-India Open Water Swim by a Couple

BENGALURU, India, May 4, 2026 /PRNewswire/ -- Manipal Hospitals, India's largest pan-India multispecialty hospital network by…

2 hours ago